Urination disorder-alleviating agent
AssigneeZeria Pharmaceutical Co., Ltd.
InventorsTakanori OKUBO, Tomoharu MIYAGAWA, Kenji NAGAHAMA
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to develop a urination disorder-alleviating agent which has a sufficient urination disorder improving effect and can be administered chronically. The present invention relates to a urination disorder-alleviating agent comprising acotiamide or a salt thereof as an active ingredient, wherein the acotiamide or a salt thereof is orally administered in an amount of 200 to 300 mg per administration for a total of 600 to 900 mg per day to an adult.
Claims6
1-12. (canceled)
A method for alleviating urination disorder, comprising orally administering acotiamide or a salt thereof in an amount of 200 to 300 mg per administration for a total of 600 to 900 mg per day to an adult.
Dependencies are inferred from the claim text.